Literature DB >> 7933836

Isotype and affinity of anti-myeloperoxidase autoantibodies in systemic vasculitis.

E Kokolina1, L H Noël, P Nusbaum, C Geffriaud, J P Grünfeld, L Halbwachs-Mecarelli, P Lesavre.   

Abstract

The role of immunoglobulin (Ig) isotype and affinity of antimyeloperoxidase (MPO) antibodies in the clinical expression of vasculitis (organ involvement, severity and evolution) remains incompletely defined. We have determined the anti-MPO antibody isotypes, as well as the apparent affinity constant (aK) of anti-MPO IgG by using fluid phase MPO inhibition of IgG binding in an MPO specific ELISA. Twenty-eight patients with anti-MPO antibodies and necrotic and crescentic glomerulonephritis, either isolated or associated to various other organ localizations, were analyzed. Serum samples were obtained before treatment and during follow-up. No association was observed between the isotype, the level or apparent affinity of anti-MPO antibodies and the clinical symptoms, severity, and organ distribution of vasculitis, including alveolar hemorrhage. No significant correlation was found between the apparent affinity and the level of anti-MPO IgG. However, the presence of anti-MPO IgM was clearly associated with low affinity anti-MPO IgG and vice versa. Furthermore, in a longitudinal study, high levels of anti-MPO IgM, when present, were observed early in the course of the disease and in some cases preceded the reappearance of anti-MPO IgG during relapses. High affinity anti-MPO IgG were usually present before treatment. Immunosuppressive therapy resulted in decreased apparent affinity and level of anti-MPO IgG. Importantly, anti-MPO IgG level increased during relapses but the affinity of these IgG autoantibodies remained low.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7933836     DOI: 10.1038/ki.1994.257

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases.

Authors:  H Chikazawa; K Nishiya; A Matsumori; K Hashimoto
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

2.  Avidity of thyroglobulin antibody in sera from patients with Hashimoto's thyroiditis with different thyroid functional status.

Authors:  Y Zhang; Y Gao; M Li; L Xie; Y Huang; Y Gao; X Guo
Journal:  Clin Exp Immunol       Date:  2010-05-10       Impact factor: 4.330

3.  A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditions.

Authors:  I C Locke; B Leaker; G Cambridge
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

4.  Titre and affinity of propylthiouracil-induced anti-myeloperoxidase antibodies are closely associated with the development of clinical vasculitis.

Authors:  Hua Ye; Ying Gao; Xiao-Hui Guo; Ming-Hui Zhao
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

5.  The avidity of PR3-ANCA in patients with granulomatosis with polyangiitis during follow-up.

Authors:  M J Kemna; W Schlumberger; P van Paassen; C Dähnrich; J G M C Damoiseaux; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2016-05-23       Impact factor: 4.330

6.  MPO-ANCA crescentic glomerulonephritis complicated by membranous nephropathy: MPO demonstrated in epimembranous deposits.

Authors:  Kei Matsumoto; Hirokazu Honda; Takanori Shibata; Daisuke Sanada; Yukihiro Wada; Eijin Ashikaga; Aki Kuroki; Kozo Kitazawa; Tadao Akizawa
Journal:  NDT Plus       Date:  2009-08-24

7.  Epitope analysis of anti-myeloperoxidase antibodies in patients with ANCA-associated vasculitis.

Authors:  Shen-Ju Gou; Peng-Cheng Xu; Min Chen; Ming-Hui Zhao
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.